CHGA and neoplasm: Therefore, we foresee that the OC% metric can be combined with the existing prognosis predictors (e.g., SSTR avidity, tumor grade, Chromogranin A, multi‐gene molecular assays) to enhance risk stratification tools or prognostic models.